Literature DB >> 26680373

Eomesodermin(lo) CTLA4(hi) Alloreactive CD8+ Memory T Cells Are Associated With Prolonged Renal Transplant Survival Induced by Regulatory Dendritic Cell Infusion in CTLA4 Immunoglobulin-Treated Nonhuman Primates.

Mohamed B Ezzelarab1, Lien Lu, Hao Guo, Alan F Zahorchak, William F Shufesky, David K C Cooper, Adrian E Morelli, Angus W Thomson.   

Abstract

BACKGROUND: Memory T cells (Tmem), particularly those resistant to costimulation blockade (CB), are a major barrier to transplant tolerance. The transcription factor Eomesodermin (Eomes) is critical for Tmem development and maintenance, but its expression by alloactivated T cells has not been examined in nonhuman primates.
METHODS: We evaluated Eomes and coinhibitory cytotoxic T lymphocyte antigen-4 (CTLA4) expression by alloactivated rhesus monkey T cells in the presence of CTLA4 immunoglobulin, both in vitro and in renal allograft recipients treated with CTLA4Ig, with or without regulatory dendritic cell (DCreg) infusion.
RESULTS: In normal monkeys, CD8+ T cells expressed significantly more Eomes than CD4+ T cells. By contrast, CD8+ T cells displayed minimal CTLA4. Among T cell subsets, central Tmem (Tcm) expressed the highest levels of Eomes. Notably, Eomes(lo)CTLA4(hi) cells displayed higher levels of CD25 and Foxp3 than Eomes(hi)CTLA4(lo) CD8+ T cells. After allostimulation, distinct proliferating Eomes(lo)CTLA4(hi) and Eomes(hi)CTLA4(lo) CD8+ T cell populations were identified, with a high proportion of Tcm being Eomes(lo)CTLA4(hi). CB with CTLA4Ig during allostimulation of CD8+ T cells reduced CTLA4 but not Eomes expression, significantly reducing Eomes(lo)CTLA4(hi) cells. After transplantation with CB and rapamycin, donor-reactive Eomes(lo)CTLA4(hi) CD8+ T cells were reduced. However, in monkeys also given DCreg, absolute numbers of these cells were elevated significantly.
CONCLUSIONS: Low Eomes and high CTLA4 expression by donor-reactive CD8+ Tmem is associated with prolonged renal allograft survival induced by DCreg infusion in CTLA4Ig-treated monkeys. Prolonged allograft survival associated with DCreg infusion may be related to maintenance of donor-reactive Eomes(lo)CTLA4(hi) Tcm.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26680373      PMCID: PMC4685739          DOI: 10.1097/tp.0000000000000871

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  65 in total

Review 1.  CD8+ regulatory T cells in solid organ transplantation.

Authors:  Carole Guillonneau; Elodie Picarda; Ignacio Anegon
Journal:  Curr Opin Organ Transplant       Date:  2010-12       Impact factor: 2.640

2.  Three-year outcomes from BENEFIT-EXT: a phase III study of belatacept versus cyclosporine in recipients of extended criteria donor kidneys.

Authors:  J O Medina Pestana; J M Grinyo; Y Vanrenterghem; T Becker; J M Campistol; S Florman; V D Garcia; N Kamar; P Lang; R C Manfro; P Massari; M D C Rial; M A Schnitzler; S Vitko; T Duan; A Block; M B Harler; A Durrbach
Journal:  Am J Transplant       Date:  2012-02-02       Impact factor: 8.086

Review 3.  Cell therapy as a strategy to minimize maintenance immunosuppression in solid organ transplant recipients.

Authors:  Edward K Geissler; James A Hutchinson
Journal:  Curr Opin Organ Transplant       Date:  2013-08       Impact factor: 2.640

4.  Intracellular trafficking of CTLA-4 and focal localization towards sites of TCR engagement.

Authors:  P S Linsley; J Bradshaw; J Greene; R Peach; K L Bennett; R S Mittler
Journal:  Immunity       Date:  1996-06       Impact factor: 31.745

Review 5.  Tolerogenic dendritic cells and their role in transplantation.

Authors:  Mohamed Ezzelarab; Angus W Thomson
Journal:  Semin Immunol       Date:  2011-07-07       Impact factor: 11.130

6.  An antagonist IL-15/Fc protein prevents costimulation blockade-resistant rejection.

Authors:  S Ferrari-Lacraz; X X Zheng; Y S Kim; Y Li; W Maslinski; X C Li; T B Strom
Journal:  J Immunol       Date:  2001-09-15       Impact factor: 5.422

7.  An MHC-defined primate model reveals significant rejection of bone marrow after mixed chimerism induction despite full MHC matching.

Authors:  C P Larsen; A Page; K H Linzie; M Russell; T Deane; L Stempora; E Strobert; M C T Penedo; T Ward; R Wiseman; D O'Connor; W Miller; S Sen; K Singh; L S Kean
Journal:  Am J Transplant       Date:  2010-09-17       Impact factor: 8.086

8.  A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study).

Authors:  F Vincenti; B Charpentier; Y Vanrenterghem; L Rostaing; B Bresnahan; P Darji; P Massari; G A Mondragon-Ramirez; M Agarwal; G Di Russo; C-S Lin; P Garg; C P Larsen
Journal:  Am J Transplant       Date:  2010-03       Impact factor: 8.086

9.  CD152 (CTLA-4) regulates effector functions of CD8+ T lymphocytes by repressing Eomesodermin.

Authors:  Johannes K Hegel; Karin Knieke; Paula Kolar; Steven L Reiner; Monika C Brunner-Weinzierl
Journal:  Eur J Immunol       Date:  2009-03       Impact factor: 5.532

Review 10.  Diversity in T cell memory: an embarrassment of riches.

Authors:  Stephen C Jameson; David Masopust
Journal:  Immunity       Date:  2009-12-18       Impact factor: 31.745

View more
  17 in total

Review 1.  Regulatory dendritic cells for human organ transplantation.

Authors:  Angus W Thomson; Diana M Metes; Mohamed B Ezzelarab; Dalia Raïch-Regué
Journal:  Transplant Rev (Orlando)       Date:  2019-05-13       Impact factor: 3.943

Review 2.  Impact of infection on transplantation tolerance.

Authors:  Shuangjin Yu; Chang Su; Xunrong Luo
Journal:  Immunol Rev       Date:  2019-09-19       Impact factor: 12.988

Review 3.  Tolerogenic dendritic cells in organ transplantation.

Authors:  Jordi Ochando; Farideh Ordikhani; Stefan Jordan; Peter Boros; Angus W Thomson
Journal:  Transpl Int       Date:  2019-10-29       Impact factor: 3.782

4.  Renal Allograft Survival in Nonhuman Primates Infused With Donor Antigen-Pulsed Autologous Regulatory Dendritic Cells.

Authors:  M B Ezzelarab; D Raich-Regue; L Lu; A F Zahorchak; A Perez-Gutierrez; A Humar; M Wijkstrom; M Minervini; R W Wiseman; D K C Cooper; A E Morelli; A W Thomson
Journal:  Am J Transplant       Date:  2017-02-02       Impact factor: 8.086

5.  Preliminary assessment of the feasibility of autologous myeloid-derived suppressor cell infusion in non-human primate kidney transplantation.

Authors:  Mohamed B Ezzelarab; Angelica Perez-Gutierrez; Abhinav Humar; Martin Wijkstrom; Alan F Zahorchak; Lien Lu-Casto; Yu-Chao Wang; Roger W Wiseman; Marta Minervini; Angus W Thomson
Journal:  Transpl Immunol       Date:  2019-07-19       Impact factor: 1.708

6.  High PD-L1/CD86 MFI ratio and IL-10 secretion characterize human regulatory dendritic cells generated for clinical testing in organ transplantation.

Authors:  Alan F Zahorchak; Camila Macedo; David E Hamm; Lisa H Butterfield; Diana M Metes; Angus W Thomson
Journal:  Cell Immunol       Date:  2017-09-14       Impact factor: 4.868

Review 7.  Generation and functional assessment of nonhuman primate regulatory dendritic cells and their therapeutic efficacy in renal transplantation.

Authors:  Angus W Thomson; Mohamed B Ezzelarab
Journal:  Cell Immunol       Date:  2020-03-12       Impact factor: 4.868

Review 8.  Regulatory dendritic cells for promotion of liver transplant operational tolerance: Rationale for a clinical trial and accompanying mechanistic studies.

Authors:  Angus W Thomson; Abhinav Humar; Fadi G Lakkis; Diana M Metes
Journal:  Hum Immunol       Date:  2017-10-31       Impact factor: 2.850

9.  Characterization of eomesodermin and T-bet expression by allostimulated CD8+ T cells of healthy volunteers and kidney transplant patients in relation to graft outcome.

Authors:  A Perez-Gutierrez; D M Metes; L Lu; S Hariharan; A W Thomson; M B Ezzelarab
Journal:  Clin Exp Immunol       Date:  2018-09-23       Impact factor: 4.330

Review 10.  Prospective Clinical Testing of Regulatory Dendritic Cells in Organ Transplantation.

Authors:  Angus W Thomson; Alan F Zahorchak; Mohamed B Ezzelarab; Lisa H Butterfield; Fadi G Lakkis; Diana M Metes
Journal:  Front Immunol       Date:  2016-01-28       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.